Circulating tumor cells atlas – an open-access platform capturing tumor cells heterogeneity during cancer dissemination
- 1Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology, Medical University of Gdańsk, Gdańsk, 80-210, Poland
- 2Department of Pathomorphology, Medical University of Gdańsk, Gdańsk, 80-210, Poland
- 3Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology, Medical University of Gdańsk, Gdańsk, 80-210, Poland; Corresponding author. Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology, Medical University of Gdańsk, ul. Dębinki 1, 80-210, Gdańsk, Poland.
Abstract
Circulating tumor cells (CTCs) are key cellular intermediates in the metastatic cascade and provide a minimally invasive window into tumor heterogeneity and evolution during metastatic progression. Despite this potential, the broader clinical and research utility of CTC-based liquid biopsy remains limited by the lack of standardized, image-based reference resources. We introduce CTC Atlas ( www.CTCAtlas.org ), an open-access platform integrating high-resolution images of diverse CTCs and other circulating tumor-associated cells with technical, clinical, and multi-omics data. CTC Atlas aims to support CTC identification, cross-laboratory comparisons, and clinical implementation of variable CTC-based assays. It also provides a reference framework for studying phenotypic heterogeneity during tumor dissemination, and matched circulating microenvironment associated with metastatic progression.
Related
- The Landscape of Tumor Dissemination in Leptomeningeal Disease: Mapping CTC Plasticity and Regional Heterogeneity Across Blood and CSF Compartments
- Improving Access to Clinical Guidelines Through a Centralised Digital Platform in an NHS Setting: A Quality Improvement Study
- Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells
- A Modular Continuous Flow Platform for Safe, On-demand Generation of HCF ₂ N ₃ from R-22 Gas and Access to N -CF ₂ H Triazoles
- Artificial Intelligence and Mobile Health Technologies for Improved Healthcare Access: Design and Pilot Evaluation of an Integrated Digital Health Platform for a Nigerian Teaching Hospital
BibTeX
@article{muchlinska2026circulating,
title = {{Circulating tumor cells atlas – an open-access platform capturing tumor cells heterogeneity during cancer dissemination}},
author = {Anna Muchlińska and Julia Richert and Robert Wenta and Aleksandra Parteka and Marta Popęda and Beata Pieczyńska-Uziębło and Anna Żaczek and Natalia Bednarz-Knoll},
journal = {Advances in Cancer Biology - Metastasis},
year = {2026},
month = oct,
doi = {10.1016/j.adcanc.2026.100221},
url = {https://doi.org/10.1016/j.adcanc.2026.100221},
note = {CC BY},
}
RIS
TY - JOUR
TI - Circulating tumor cells atlas – an open-access platform capturing tumor cells heterogeneity during cancer dissemination
AU - Anna Muchlińska
AU - Julia Richert
AU - Robert Wenta
AU - Aleksandra Parteka
AU - Marta Popęda
AU - Beata Pieczyńska-Uziębło
AU - Anna Żaczek
AU - Natalia Bednarz-Knoll
PY - 2026
DA - 2026/10/30
JO - Advances in Cancer Biology - Metastasis
DO - 10.1016/j.adcanc.2026.100221
UR - https://doi.org/10.1016/j.adcanc.2026.100221
AB - Circulating tumor cells (CTCs) are key cellular intermediates in the metastatic cascade and provide a minimally invasive window into tumor heterogeneity and evolution during metastatic progression. Despite this potential, the broader clinical and research utility of CTC-based liquid biopsy remains limited by the lack of standardized, image-based reference resources. We introduce CTC Atlas ( www.CTCAtlas.org ), an open-access platform integrating high-resolution images of diverse CTCs and other circulating tumor-associated cells with technical, clinical, and multi-omics data. CTC Atlas aims to support CTC identification, cross-laboratory comparisons, and clinical implementation of variable CTC-based assays. It also provides a reference framework for studying phenotypic heterogeneity during tumor dissemination, and matched circulating microenvironment associated with metastatic progression.
SN - 2667-3940
ER -